Perrigo (NYSE:PRGO) updated its FY19 earnings guidance on Thursday. The company provided EPS guidance of $3.75-4.05 for the period, compared to the Thomson Reuters consensus EPS estimate of $3.94. Perrigo also updated its FY 2019 guidance to $3.75-4.05 EPS.
Several research firms have recently weighed in on PRGO. Wells Fargo & Co reiterated a hold rating on shares of Perrigo in a research note on Tuesday, July 2nd. ValuEngine upgraded Perrigo from a strong sell rating to a sell rating in a research note on Thursday, August 1st. SunTrust Banks raised their target price on Perrigo to $51.00 and gave the stock a hold rating in a research note on Monday, May 20th. Finally, Cantor Fitzgerald cut their target price on Perrigo from $107.00 to $60.00 and set an overweight rating for the company in a research note on Wednesday, June 12th. One investment analyst has rated the stock with a sell rating, five have issued a hold rating and two have given a buy rating to the company’s stock. The stock has an average rating of Hold and an average price target of $59.50.
NYSE PRGO traded down $0.14 during trading hours on Friday, hitting $46.90. The company had a trading volume of 2,246,144 shares, compared to its average volume of 1,299,435. Perrigo has a 52 week low of $36.28 and a 52 week high of $78.90. The company’s 50 day moving average is $50.31. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.64 and a quick ratio of 1.14. The company has a market capitalization of $6.40 billion, a price-to-earnings ratio of 10.31, a price-to-earnings-growth ratio of 2.83 and a beta of 1.40.
The business also recently announced a quarterly dividend, which will be paid on Tuesday, September 17th. Shareholders of record on Friday, August 30th will be paid a $0.21 dividend. The ex-dividend date of this dividend is Thursday, August 29th. This represents a $0.84 annualized dividend and a yield of 1.79%. Perrigo’s dividend payout ratio is currently 18.46%.
Perrigo Company plc, a healthcare company, manufactures and supplies over-the-counter (OTC) healthcare products, infant formulas, branded OTC products, and generic pharmaceutical products. The company operates through Consumer Healthcare Americas, Consumer Healthcare International, and Prescription Pharmaceuticals segments.
Further Reading: What is dollar cost averaging (DCA)?
Receive News & Ratings for Perrigo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Perrigo and related companies with MarketBeat.com's FREE daily email newsletter.